Washington Nephrology Associates, LLP

Washington Nephrology Associates, LLP Washington Nephrology Associates is a partnership of physicians practicing Nephrology in the Greater Metropolitan DC and Baltimore area since 1984

Washington Nephrology Associates, LLP. (WNA) is a partnership of physicians practicing Nephrology in the Greater Metropolitan DC and Baltimore area since 1984. The group’s history began much earlier, however, with the professional association of Larry Siegel MD, James H. Knepshild MD, and William J. Cirksena MD in 1965. These nephrologists established the Metropolitan Washington Renal-Dialysis Center in Bethesda, MD, the first outpatient dialysis center in the Washington, DC area, and worked with Congress on the landmark 1972 legislation that extended Medicare benefits to patients with end-stage renal disease. In the 1980’s, they joined forces with several other nephrologists in the Maryland and Virginia suburbs, and Washington Nephrology Associates was officially born. Over the years, the partnership has continued to grow, and now has strong presences in Washington, Baltimore, Bethesda, Alexandria, Takoma Park, Silver Spring, Fairfax, Woodbridge, and Annapolis. Our physicians are all board certified or board eligible in nephrology. A number of our nephrologists are on the faculty at the Georgetown University School of Medicine and the George Washington University School of Medicine and Health Sciences, and are active in teaching medical students and residents. Many of our physicians are listed as top nephrologists in Washingtonian Magazine as well as other local publications. Services provided include diagnoses and management of:
•All types of kidney disease
•Hypertension
•Electrolyte abnormalities such as abnormal sodium or potassium levels
•End-stage renal disease (kidney failure)
•Kidney transplant evaluation and follow-up care
•Kidney stones
•Urinary tract infections (UTI)
•Other urinary abnormalities

09/07/2024

According to WHO, nearly 18 million people die each year from cardiovascular diseases, making them the leading cause of death worldwide.

A new Series in The Lancet Digital Health demonstrates the potential of artificial intelligence and digital technologies to transform cardiovascular care globally.

Explore the Series ➡️ https://hubs.li/Q02MJFwG0

👇 Figure: Lancet infographic highlighting the barriers to the clinical implementation of AI technology in cardiology.

Address

Woodbridge, VA

Alerts

Be the first to know and let us send you an email when Washington Nephrology Associates, LLP posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category